Literature DB >> 24613284

Overexpression of recombinant human antiquitin in E. coli: partial enzyme activity in selected ALDH7A1 missense mutations associated with pyridoxine-dependent epilepsy.

Marion B Coulter-Mackie1, Sylvia Tiebout2, Clara van Karnebeek3, Sylvia Stockler4.   

Abstract

Pyridoxine-dependent epilepsy (PDE) is an autosomal recessive disorder characterized by early onset seizures responsive to pyridoxine and caused by a defect in the α-aminoadipic semialdehyde dehydrogenase (antiquitin) gene (ALDH7A1). We selected four PDE-associated missense ALDH7A1 mutations, p.V367F, p.F410L, p.Q425R, and p.C450S, generated them in a recombinant human antiquitin cDNA with expression in E. coli at either 30°C or 37°C. One mutation, p.C450S, demonstrated substantial activity after expression at both temperatures, potentially contributing to milder biochemical and clinical phenotypes. The p.Q425R mutation yielded no activity at either temperature. The other two mutations yielded significant enzymatic activity at 30°C and markedly reduced activity at 37°C. For these latter three mutations, the markedly reduced or absent enzymatic activity resulting from expression at 37°C may be consistent with pathogenicity.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiquitin; Enzymatic activity; Metabolic epilepsy; Missense mutation; Pyridoxine

Mesh:

Substances:

Year:  2014        PMID: 24613284     DOI: 10.1016/j.ymgme.2014.02.010

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  6 in total

1.  Impact of disease-Linked mutations targeting the oligomerization interfaces of aldehyde dehydrogenase 7A1.

Authors:  David A Korasick; John J Tanner; Michael T Henzl
Journal:  Chem Biol Interact       Date:  2017-01-10       Impact factor: 5.192

2.  Pyridoxine-dependent epilepsy (PDE-ALDH7A1) in adulthood: A Dutch pilot study exploring clinical and patient-reported outcomes.

Authors:  L A Tseng; L Teela; M C Janssen; L A Bok; M A A P Willemsen; R F Neuteboom; L Haverman; S M Gospe; C R Coughlin; C D M van Karnebeek
Journal:  Mol Genet Metab Rep       Date:  2022-03-04

Review 3.  The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: A common epileptic encephalopathy.

Authors:  Curtis R Coughlin; Michael A Swanson; Elaine Spector; Naomi J L Meeks; Kathryn E Kronquist; Mezhgan Aslamy; Michael F Wempe; Clara D M van Karnebeek; Sidney M Gospe; Verena G Aziz; Becky P Tsai; Hanlin Gao; Peter L Nagy; Keith Hyland; Silvy J M van Dooren; Gajja S Salomons; Johan L K Van Hove
Journal:  J Inherit Metab Dis       Date:  2019-02-22       Impact factor: 4.982

Review 4.  Impact of missense mutations in the ALDH7A1 gene on enzyme structure and catalytic function.

Authors:  David A Korasick; John J Tanner
Journal:  Biochimie       Date:  2020-09-19       Impact factor: 4.079

Review 5.  Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention.

Authors:  Jie Gao; Yue Hao; Xiangshu Piao; Xianhong Gu
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

6.  Case report: Fatal outcome of pyridoxine-dependent epilepsy presenting as respiratory distress followed by a circulatory collapse.

Authors:  Giulia Aquilano; Agnes Linnér; Sofia Ygberg; Tommy Stödberg; Ewa Henckel
Journal:  Front Pediatr       Date:  2022-07-28       Impact factor: 3.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.